---
figid: PMC6696099__ijms-20-03624-g001
figlink: /pmc/articles/PMC6696099/figure/ijms-20-03624-f001/
number: F1
caption: Proposed targeting approaches involving ACSL isoenzymes in cancer. (A) ACSL1
  and glycolytic pathway co-targeting in colon cancer (red), and ACSL1 single targeting
  breast cancer (blue). (B) ACSL3, CPT1 and the mammalian target of rapamycin complex
  1 (mTORC1) co-targeting in lung cancer (red) and the combination of ACSL3 inhibition
  with ER stress inducers in lung and prostate cancer. (C) Combined ACSL4 and SCD1
  inhibition in colon cancer (red) and ACSL4 indirect targeting via the p38 MAPK pathway
  inhibition in liver cancer (blue). (D) ACSL5 and Topoisomerase II (Topo II) co-targeting
  with a potential therapeutic benefit in glioma.
pmcid: PMC6696099
papertitle: Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy.
reftext: Matteo Rossi Sebastiano, et al. Int J Mol Sci. 2019 Aug;20(15):3624.
pmc_ranked_result_index: '35855'
pathway_score: 0.9036899
filename: ijms-20-03624-g001.jpg
figtitle: Proposed targeting approaches involving ACSL isoenzymes in cancer
year: '2019'
organisms: Homo sapiens
ndex: e2a44440-de99-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6696099__ijms-20-03624-g001.html
  '@type': Dataset
  description: Proposed targeting approaches involving ACSL isoenzymes in cancer.
    (A) ACSL1 and glycolytic pathway co-targeting in colon cancer (red), and ACSL1
    single targeting breast cancer (blue). (B) ACSL3, CPT1 and the mammalian target
    of rapamycin complex 1 (mTORC1) co-targeting in lung cancer (red) and the combination
    of ACSL3 inhibition with ER stress inducers in lung and prostate cancer. (C) Combined
    ACSL4 and SCD1 inhibition in colon cancer (red) and ACSL4 indirect targeting via
    the p38 MAPK pathway inhibition in liver cancer (blue). (D) ACSL5 and Topoisomerase
    II (Topo II) co-targeting with a potential therapeutic benefit in glioma.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK10
  - ACSL4
  - MAPK13
  - ACSL3
  - MAPK1
  - CHPT1
  - ACSL1
  - MAPK14
  - MAPK11
  - MAPK9
  - MAPK12
  - SREBF1
  - MAPK8
  - MAPK3
  - Fatty acids
  - Glucose
  - Triacsin C
  - Acyl
  - Acyl CoAs
  - ATP
  - Bromo-CAMP
  - Etoposide
  - Thiazolidinediones
  - acidosis
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: ACSL4
  symbol: ACSL4
  source: hgnc_symbol
  hgnc_symbol: ACSL4
  entrez: '2182'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: ACSL3
  symbol: ACSL3
  source: hgnc_symbol
  hgnc_symbol: ACSL3
  entrez: '2181'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: CPT1
  symbol: CPT1
  source: hgnc_alias_symbol
  hgnc_symbol: CHPT1
  entrez: '56994'
- word: ACSL1
  symbol: ACSL1
  source: hgnc_symbol
  hgnc_symbol: ACSL1
  entrez: '2180'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: SREBP1
  symbol: SREBP1
  source: hgnc_alias_symbol
  hgnc_symbol: SREBF1
  entrez: '6720'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
chemicals:
- word: Fatty acids
  source: MESH
  identifier: D005227
- word: Glucose
  source: MESH
  identifier: D005947
- word: Triacsin C
  source: MESH
  identifier: C034613
- word: Acyl
  source: MESH
  identifier: D000214
- word: Acyl CoAs
  source: MESH
  identifier: D000214
- word: ATP
  source: MESH
  identifier: D000255
- word: Bromo-CAMP
  source: MESH
  identifier: C106170
- word: Etoposide
  source: MESH
  identifier: D005047
- word: Thiazolidinediones
  source: MESH
  identifier: D045162
diseases:
- word: acidosis
  source: MESH
  identifier: D000138
figid_alias: PMC6696099__F1
redirect_from: /figures/PMC6696099__F1
figtype: Figure
---
